Article abstract


Nature Cell Biology 9, 755 - 764 (2007)
Published online: 18 June 2007 | doi:10.1038/ncb1602

BACE1 regulates voltage-gated sodium channels and neuronal activity

Doo Yeon Kim1,5, Bryce W. Carey1,5, Haibin Wang2, Laura A. M. Ingano1, Alexander M. Binshtok2, Mary H. Wertz1, Warren H. Pettingell1, Ping He3, Virginia M.-Y. Lee4, Clifford J. Woolf2 & Dora M. Kovacs1


BACE1 activity is significantly increased in the brains of Alzheimer's disease patients, potentially contributing to neurodegeneration. The voltage-gated sodium channel (Nav1) beta2-subunit (beta2), a type I membrane protein that covalently binds to Nav1 alpha-subunits, is a substrate for BACE1 and gamma-secretase. Here, we find that BACE1–gamma-secretase cleavages release the intracellular domain of beta2, which increases mRNA and protein levels of the pore-forming Nav1.1 alpha-subunit in neuroblastoma cells. Similarly, endogenous beta2 processing and Nav1.1 protein levels are elevated in brains of BACE1-transgenic mice and Alzheimer's disease patients with high BACE1 levels. However, Nav1.1 is retained inside the cells and cell surface expression of the Nav1 alpha-subunits and sodium current densities are markedly reduced in both neuroblastoma cells and adult hippocampal neurons from BACE1-transgenic mice. BACE1, by cleaving beta2, thus regulates Nav1 alpha-subunit levels and controls cell-surface sodium current densities. BACE1 inhibitors may normalize membrane excitability in Alzheimer's disease patients with elevated BACE1 activity.

Top
  1. Neurobiology of Disease Laboratory, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
  2. Neural Plasticity Research Group, Department of Anaesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
  3. Haldeman Laboratory of Molecular and Cellular Neurobiology, Sun Health Research Institute, Sun City, AZ 85351, USA.
  4. Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, PA 19104, USA.
  5. These authors contributed equally to this work.

Correspondence to: Dora M. Kovacs1 e-mail: dora_kovacs@hms.harvard.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.


Extra navigation

Subscribe to Nature Cell Biology

Subscribe

naturejobs

natureproducts